Fiona Lucas
About Fiona Lucas
Fiona Lucas is a Principal Scientist at BenevolentAI in London, with extensive experience in molecular pharmacology and AI-driven drug discovery.
Title
Fiona Lucas is currently a Principal Scientist at BenevolentAI in London, England, United Kingdom.
Career at BenevolentAI
At BenevolentAI, Fiona Lucas is involved in the development of AI-driven drug discovery platforms. As a Principal Scientist, she mentors junior scientists and researchers, guiding them in integrating AI and machine learning in biological research. She also participated as a speaker at the AI in Drug Discovery conference in 2022.
Previous Experience at Syngenta
Before joining BenevolentAI, Fiona Lucas worked at Syngenta as a Principal Scientist from 2019 to 2021. During her tenure, she contributed to research and development in various scientific projects.
Roles at UCB
Fiona Lucas held several positions at UCB, starting as an Assay Design Scientist from 2017 to 2018 and later advancing to Senior Scientist - Molecular Pharmacology from 2018 to 2019. Her work in Slough, United Kingdom, focused on molecular pharmacology research.
Experience at Imperial College London and Berkshire Healthcare NHS Foundation Trust
From 2014 to 2017, Fiona Lucas was a Science Writer in the Cancer Screening and Prevention Group at Imperial College London. Concurrently, she served as a member of the 'Public and Patient Involvement in Research' steering committee at Berkshire Healthcare NHS Foundation Trust from 2012 to 2015.
Educational Background
Fiona Lucas earned a PhD in Developmental Neuroscience from King's College London, where she studied from 1995 to 1999. She also holds a BSc Hons in Applied Biology from Imperial College London and attended the Dyson School of Design Engineering from 1991 to 1995.